EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsMichael T. McCabe, Caretha L. Creasy, Heidi M. Ott et al.|Nature|2012Cited by 1.8k
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)Michael T. McCabe, Caretha L. Creasy, Alan P. Graves et al.|Proceedings of the National Academy of Sciences|2012Cited by 488
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2Sharad K. Verma, William H. Miller, Ryan G. Kruger et al.|ACS Medicinal Chemistry Letters|2012Cited by 377
Long Residence Time Inhibition of EZH2 in Activated Polycomb Repressive Complex 2Glenn S. Van Aller, Ryan G. Kruger, Melissa B. Pappalardi et al.|ACS Chemical Biology|2013Cited by 58
A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) HypertrimethylationHeidi M. Ott, Michael T. McCabe, Alan P. Graves et al.|Molecular Cancer Therapeutics|2014Cited by 46